Cargando…
A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma
BACKGROUND: Immune-related genes (IRGs) are highly relevant to the progression and prognosis of esophageal squamous cell carcinoma (ESCC). A prognostic signature could be reliable in stratifying ESCC patients according to the risk score, which may help manage systematic treatments. In this study, a...
Autores principales: | Xu, Tao, Dai, Tianyang, Zeng, Peiyuan, Guo, Yunfen, He, Kaiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798451/ https://www.ncbi.nlm.nih.gov/pubmed/35116551 http://dx.doi.org/10.21037/tcr-20-2665 |
Ejemplares similares
-
Identification of RHEX as a novel biomarker related to progression and immunity of non-small cell lung carcinoma
por: Xu, Tao, et al.
Publicado: (2021) -
Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes
por: Zhang, Chaoqi, et al.
Publicado: (2020) -
A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma
por: Song, Jiahang, et al.
Publicado: (2021) -
A five-gene signature to predict the overall survival time of patients with esophageal squamous cell carcinoma
por: He, Wenwu, et al.
Publicado: (2019) -
A novel immune-related prognostic signature based on Chemoradiotherapy sensitivity predicts long-term survival in patients with esophageal squamous cell carcinoma
por: Zhang, Zewei, et al.
Publicado: (2023)